Double Bond Pharmaceutical Competitors and Similar CompaniesClear all

Turning Point Therapeutics's competitors and similar companies include NATCO Pharma and Pharmstandard.
Turning Point Therapeutics
Turning Point Therapeutics
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
NATCO Pharma
NATCO Pharma
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
Pharmstandard
Pharmstandard
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
Founding Date
Founding Date
2013
Founding Date
1981
Founding Date
2003
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Tags
Locations
Locations
San Diego, US HQ
Locations
Hyderabad, IN HQ
Central Hope Town, IN
Chennai, IN
Hyderabad, IN
Santola, IN
Vijayapuri North, IN
Locations
Dolgoprudny, RU HQ
Kursk, RU
Moscow, RU
Petrovo Dalnee, RU
Tomsk, RU
Ufa, RU
Vol'ginskii, RU
Employees
Employees
474% decrease
Employees
4,016
Employees
1,77814% increase

Financial

Revenue (est.)
Revenue (est.)
$30.8m (FY, 2021)
Revenue (est.)
₹40.8b (FY, 2026)
Revenue (est.)
₽152.1b (FY, 2024)
Cost of goods
Cost of goods
N/A
Cost of goods
₹6.9b (FY, 2026)
Cost of goods
₽117b (FY, 2024)
Gross profit
Gross profit
N/A
Gross profit
₹36.9b (FY, 2026)
Gross profit
₽35.2b (FY, 2024)
Net income
Net income
($236.6m) (FY, 2021)
Net income
₹13.7b (FY, 2026)
Net income
₽22.7b (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

NATCO Pharma
HQ
Hyderabad, IN
Employees
4,016

NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).

View company
Pharmstandard
HQ
Dolgoprudny, RU

Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.

View company